Bruker Corporation (BRKR)

Liquidity ratios

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Current ratio 1.60 1.66 1.65 1.81 1.80 1.89 2.08 2.03 2.31 2.36 2.55 2.56 2.63 2.16 2.06 2.06 2.43 2.67 2.61 2.60
Quick ratio 0.61 0.57 0.60 0.76 0.86 0.89 1.06 1.03 1.22 1.21 1.38 1.51 1.69 1.13 1.09 1.14 1.35 1.39 1.50 1.54
Cash ratio 0.14 0.11 0.14 0.30 0.42 0.36 0.56 0.59 0.71 0.72 0.88 1.04 1.24 0.73 0.74 0.79 0.92 0.90 1.06 1.11

Bruker Corporation's current ratio has been relatively stable over the past few years, ranging between 1.60 and 2.67. This indicates that the company has a strong ability to cover its short-term obligations with its current assets.

In contrast, Bruker's quick ratio has shown more variability, dropping from 1.69 at the end of 2021 to 0.61 by the end of 2024. This may suggest a decreasing ability to meet its immediate liabilities without relying on inventory.

The cash ratio, which measures the company's ability to cover its current liabilities with its cash and cash equivalents, has also experienced a downward trend, falling from 1.24 in December 2021 to 0.14 by the end of June 2024. This indicates a potential weakening in the company's liquidity position.

Overall, while Bruker Corporation has maintained a healthy current ratio, the declining trend in its quick and cash ratios raises some concerns about its short-term liquidity position. It would be prudent for the company to monitor and potentially take steps to improve its liquidity management in the future.

Additional liquidity measure

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash conversion cycle days 242.29 287.16 291.83 276.72 258.79 269.28 272.57 257.34 253.42 237.79 239.94 234.44 232.91 240.39 241.83 239.48 255.87 266.33 251.66 229.66

The cash conversion cycle of Bruker Corporation has shown some fluctuations over the years, ranging from a low of 229.66 days to a high of 291.83 days. The cash conversion cycle measures the time it takes for a company to convert its investments in inventory and other resources into cash flows from sales.

A longer cash conversion cycle indicates that the company is taking longer to recover its cash tied up in operations. This could be due to factors such as slower inventory turnover, extended receivables collection period, and delayed payment of accounts payable.

Bruker Corporation's cash conversion cycle has generally been above 200 days, suggesting that the company may be facing challenges in efficiently managing its working capital. It is important for the company to closely monitor and improve its inventory management, accounts receivable collection, and payment practices to optimize its cash flow and overall financial performance.